ArticleFrontiers in cardiovascular medicine2025
Case Report: Diagnostic challenges and therapeutic approaches in cardiac intimal sarcoma: a rare clinical case study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary cardiac tumors are exceedingly rare, with the majority being benign, while malignant tumors are even less common. Cardiac intimal sarcoma represents a rare and aggressive variant of primary cardiac tumors, characterized by its stromal origin and frequent association with genetic abnormalities. They typically present with non-specific symptoms, making early diagnosis difficult. Case demonstration: A 61-year-old female patient with a medical history notable for multiple neoplasms and surgical interventions is discussed. In 2006, she was diagnosed with uterine fibroids and underwent surgical excision. A decade later, in 2016, she was diagnosed with breast cancer, for which she received surgical treatment followed by radiotherapy. In 2023, the patient developed bilateral lower extremity arterial embolism, and a thrombectomy revealed a mixed thrombus. In 2024, she experienced a recurrence of arterial embolism in the left lower extremity. Following a thrombectomy, the embolus was identified as a myxoma, and subsequent echocardiographic evaluation revealed a mass within the left ventricle. Surgical intervention was performed to excise the left ventricular mass, and the final postoperative pathological examination confirmed the diagnosis of cardiac intimal sarcoma. Conclusion: Cardiac intimal sarcoma of the left ventricle is an uncommon condition, and the absence of specific symptoms complicates early diagnosis, frequently resulting in misdiagnosis. While chemotherapy and gene-targeted therapies may improve patient outcomes, early and complete surgical resection is crucial for achieving long-term survival in individuals with cardiac intimal sarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.